ArTS Archivio della ricerca di Trieste

RUARO, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.344
AS - Asia 7.474
EU - Europa 5.121
SA - Sud America 1.393
Continente sconosciuto - Info sul continente non disponibili 582
AF - Africa 234
OC - Oceania 44
Totale 23.192
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.971
SG - Singapore 2.484
IT - Italia 2.036
CN - Cina 1.470
BR - Brasile 1.117
VN - Vietnam 1.026
HK - Hong Kong 741
BD - Bangladesh 494
KR - Corea 428
DE - Germania 378
GB - Regno Unito 346
FR - Francia 340
SE - Svezia 307
NL - Olanda 280
FI - Finlandia 258
PL - Polonia 236
RU - Federazione Russa 206
IN - India 171
CA - Canada 169
BG - Bulgaria 163
IE - Irlanda 153
AR - Argentina 99
MX - Messico 93
AT - Austria 83
ID - Indonesia 81
CH - Svizzera 73
IQ - Iraq 72
MA - Marocco 67
TR - Turchia 66
JP - Giappone 63
ES - Italia 56
PH - Filippine 54
ZA - Sudafrica 49
EC - Ecuador 43
IR - Iran 39
AU - Australia 38
PK - Pakistan 38
SA - Arabia Saudita 38
CO - Colombia 37
UA - Ucraina 34
EG - Egitto 33
CL - Cile 26
UZ - Uzbekistan 26
VE - Venezuela 24
TH - Thailandia 23
PY - Paraguay 21
AE - Emirati Arabi Uniti 20
CZ - Repubblica Ceca 20
RO - Romania 20
BE - Belgio 17
GR - Grecia 16
JM - Giamaica 16
HN - Honduras 15
CR - Costa Rica 14
JO - Giordania 13
KE - Kenya 13
MY - Malesia 13
TW - Taiwan 13
IL - Israele 12
SN - Senegal 12
AZ - Azerbaigian 11
PE - Perù 11
RS - Serbia 11
DZ - Algeria 10
KZ - Kazakistan 10
NI - Nicaragua 10
NP - Nepal 10
OM - Oman 10
PA - Panama 10
TN - Tunisia 10
PT - Portogallo 9
AL - Albania 8
AO - Angola 8
BY - Bielorussia 8
DK - Danimarca 8
GT - Guatemala 8
HR - Croazia 8
LK - Sri Lanka 8
BO - Bolivia 7
HU - Ungheria 7
UY - Uruguay 7
BB - Barbados 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
TT - Trinidad e Tobago 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
KG - Kirghizistan 5
LT - Lituania 5
SV - El Salvador 5
CI - Costa d'Avorio 4
LB - Libano 4
LU - Lussemburgo 4
NG - Nigeria 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
YE - Yemen 4
BA - Bosnia-Erzegovina 3
CG - Congo 3
Totale 22.542
Salva come PNG Salva come JPEG
Città #
Singapore 1.415
Ashburn 1.033
San Jose 863
Hong Kong 718
Council Bluffs 621
Chandler 464
Seoul 419
Hefei 414
Ho Chi Minh City 337
Beijing 329
Trieste 312
Hanoi 253
Los Angeles 243
Columbus 234
Santa Clara 219
Boardman 215
Dallas 203
Milan 200
Chicago 193
Lauterbourg 160
Princeton 160
New York 158
Sofia 158
Dublin 143
Zgierz 142
Helsinki 139
London 139
São Paulo 115
Redmond 111
The Dalles 105
Moscow 97
Frankfurt am Main 94
Rome 92
Munich 79
Lappeenranta 78
Warsaw 75
Wilmington 75
Phoenix 72
North Bergen 70
Buffalo 68
Vienna 62
Turin 53
Naples 52
Montreal 50
Amsterdam 49
Haiphong 49
Bern 48
Casablanca 44
Tokyo 44
Atlanta 42
Nuremberg 42
Da Nang 40
Toronto 39
Denver 38
Rio de Janeiro 37
Orem 36
Boydton 35
Manchester 35
Turku 35
Mexico City 33
Florence 31
Seattle 31
Cividale del Friuli 29
Houston 29
Udine 29
Bremen 28
Chennai 28
Shanghai 28
Düsseldorf 27
Baghdad 26
Redondo Beach 26
Tehran 26
Guangzhou 25
Bologna 24
Brasília 24
Paris 24
Brooklyn 23
Dong Ket 23
Johannesburg 23
Miano 23
Mumbai 23
Bari 22
Jacksonville 21
Miami 21
Tashkent 21
Treviso 20
Hangzhou 19
Venice 19
Washington 19
Curitiba 18
Guayaquil 18
San Francisco 18
Stockholm 18
Woodbridge 18
Barnet 17
Campinas 17
Genoa 17
Palermo 17
Porto Alegre 17
Ankara 16
Totale 12.781
Salva come PNG Salva come JPEG
Nome #
Alveolar Epithelial Type II Cells 477
Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography 400
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 286
Deciphering loop gain complexity: a primer for understanding a pathophysiological trait of obstructive sleep apnea patients 271
Use of Rheology and portable Low-Field NMR for the monitoring of lung functions in cystic fibrosis patients 247
Combined use of rheology and portable low-field NMR in cystic fibrosis patients 245
Comorbidities’ Effect on IPF: Pathogenesis and Management 233
Chronic Thromboembolic Pulmonary Hypertension: An Update 229
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows 225
The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung 225
Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy 221
Interstitial lung disease in patients with antisynthetase syndrome: a retrospective case series study 216
Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage? 212
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat? 210
Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria 210
Diagnostic Accuracy of Chest Digital Tomosynthesis in Patients Recovering after COVID-19 Pneumonia 210
Radiological-pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways? 208
Emergency Laser Treatment of a Tracheobronchial Carcinoid during ECMO 203
Assessment of Treatment Effects of Aminaphtone by Capillaroscopy in a Patient with Raynaud’s Phenomenon 202
Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) 200
Aging-Related Findings of the Respiratory System in Chest Imaging: Pearls and Pitfalls 197
Accuracy of CT-Guided Core-Needle Biopsy in Diagnosis of Thoracic Lesions Suspicious for Primitive Malignancy of the Lung: A Five-Year Retrospective Analysis 196
The Treatment of Lung Involvement in Systemic Sclerosis 193
A tailored machine learning approach for mortality prediction in severe COVID-19 treated with glucocorticoids 193
Low arousal threshold: a common pathophysiological trait in patients with obstructive sleep apnea syndrome and asthma 189
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia 186
Digital Ulcers in Systemic Sclerosis 186
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study 185
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study 182
Severe COVID‐19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail? 181
Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story? 177
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients 177
A multi-national survey to identify clinicians’ perspectives concerning Proton Pump inhibitors in patients with systemic sclerosis 175
Advanced in naifold capillaroscopic analysis in systemic sclerosis 175
High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose? 173
Clinical Applications of Contrast-Enhanced Ultrasonography (CEUS) in Vascular Surgery: State-of-the-Art Narrative and Pictorial Review 172
Vascular Endothelial Damage in COPD: Where Are We Now, Where Will We Go? 171
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis 169
Clinical Evaluation of the ButterfLife Device for Simultaneous Multiparameter Telemonitoring in Hospital and Home Settings 168
Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients 164
Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS 164
Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon: A Feasibility Study 163
Editorial: Evolution in respiratory pharmacology 161
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement 161
Hematopoietic Stem Cell Transplantation in Late‐onset X‐linked Chronic Granulomatous Disease in a Female Carrier 159
Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease 156
Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study 156
Calcified Lung Nodules: A Diagnostic Challenge in Clinical Daily Practice 155
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 155
Low Arousal Threshold Estimation Predicts Failure of Mandibular Advancement Devices in Obstructive Sleep Apnea Syndrome 153
Evaluation of Correlations between Genetic Variants and High‐Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis 152
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages 152
A Systematic Review of In-situ Aortic Reconstructions for Abdominal Aortic Graft and Endograft Infections: Outcomes of Currently Available Options for Surgical Replacement 150
Successful treatment of life-threatening mycobacteriosis using adjunctive gamma-interferon therapy with genetic analysis 150
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients 149
Chronic Obstructive Pulmonary Disease definition: is it time to incorporate also the concept of lung regeneration's failure? 148
Host-Based Treatments for Severe COVID-19 146
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 146
Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction 146
Gastrointestinal Manifestations of Sarcoidosis: A State-of-the-Art, Comprehensive Review of the Literature—Practical Clinical Insights and Many Unmet Needs on Diagnosis and Treatment 145
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter-A Critical Review and Viewpoints 144
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 144
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study 142
Nailfold Capillaroscopy Analysis Can Add a New Perspective to Biomarker Research in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 140
Ultrasound and elastography in the assessment of skin involvement in systemic sclerosis: A systematic literature review focusing on validation and standardization - WSF Skin Ultrasound Group 140
Nailfold Video-Capillaroscopy in Sarcoidosis: New Perspectives and Challenges 140
Don't forget the jumper's knee in the young sportsman: evaluation of patellar tendinopathy with a high frequency ultrasound probe 140
A novel technique for conducting flexible bronchoscopy cryobiopsy under conscious sedation: An observational study 140
Advances in Diagnostics and Management of Respiratory System Diseases 139
Pulmonary fibrosis: one manifestation, various diseases 138
Novel Technique for Intentional Occlusion of Directional Branches During Complex Endovascular Aortic Repair Using Microvascular Plugs 138
Autoantibodies in sarcoidosis: innocent bystander or promising biomarker for organ involvement? 135
Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant 135
Cardiopulmonary exercise testing complements both spirometry and nuclear imaging for assessing sarcoidosis stage and for monitoring disease activity 135
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts 134
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay 134
Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis 133
Correlation between Potential Risk Factors and Pulmonary Embolism in Sarcoidosis Patients Timely Treated 132
Biomarkers in Systemic Sclerosis: An Overview 131
Monitoring COVID-19 pneumonia undergoing non-invasive respiratory support (NIRS), correlation between oscillometric reactance and Thoracic CT 131
OBSTRUCTIVE SLEEP APNEA SYNDROME (OSAS). WHAT’S NEW? 131
Valutazione dei fattori di rischio di embolia polmonare nei pazienti affetti da sarcoidosi 130
Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients 129
Oscillometry Longitudinal Data on COVID-19 Acute Respiratory Syndrome Treated with Non-Invasive Respiratory Support 128
Analyzing Sarcoidosis via Nailfold Capillaroscopy: Microvascular Insights 126
Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 125
Correlation between bone quality and microvascular damage in systemic sclerosis patients 125
Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients 124
A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis   123
Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS 123
Ultrasonography for the assessment of skin in systemic sclerosis: a systematic review 123
A versatile role for lung ultrasound in systemic autoimmune rheumatic diseases related pulmonary involvement: a narrative review 122
Capillaroscopy 2016: new perspectives in systemic sclerosis 122
A Review: The Potential Involvement of Growth Arrest-Specific 6 and Its Receptors in the Pathogenesis of Lung Damage and in Coronavirus Disease 2019 118
Pulmonary Sarcoidosis and Immune Dysregulation: A Pilot Study on Possible Correlation 118
Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis 117
Pulmonary Fibrosis: one manifestation, various diseases 114
Editorial: Osteoporosis in Rheumatic Diseases, What's New? 114
Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy 114
Exploring sarcoidosis via nailfold capillaroscopy: A window into the disease’s microvascular landscape 113
Totale 16.790
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.268
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022957 0 0 35 70 16 96 82 47 231 47 62 271
2022/20231.614 169 211 131 152 144 263 44 127 191 39 94 49
2023/20241.735 105 86 115 98 165 155 331 323 40 50 138 129
2024/20254.365 82 405 464 293 309 276 306 255 493 526 431 525
2025/202612.259 843 672 1.030 1.542 825 867 1.456 542 1.242 1.537 993 710
2026/20271.945 766 699 480 0 0 0 0 0 0 0 0 0
Totale 23.192